bioRxivMicrobiologyPreprint
Selection of Ethanol Tolerant Strains of Candida albicans by Repeated Ethanol Exposure Results in Strains with Reduced Susceptibility to Fluconazole
Abstract
Candida albicans is a commensal yeast that has important impacts on host metabolism and immune function, and can establish life-threatening infections in immunocompromised individuals. Previously, C. albicans colonization has been shown to contribute to the progression and severity of alcoholic liver disease. However, relatively little is known about how C. albicans responds to changing environmental conditions in the GI tract of individuals with alcohol use disorder, namely repeated exposure to ethanol. In this study, we repeatedly exposed C. albicans to high concentrations (10% vol/vol) of ethanol--a concentration that can be observed in the upper GI tract of humans following consumption of alcohol. Following this repeated exposure protocol, ethanol small colony (Esc) variants of C. albicans isolated from these populations exhibited increased ethanol tolerance, altered transcriptional responses to ethanol, and cross-resistance/tolerance to the frontline antifungal fluconazole. These Esc strains exhibited chromosomal copy number variations and carried polymorphisms in genes previously associated with the acquisition of fluconazole resistance during human infection. This study identifies a selective pressure that can result in evolution of fluconazole tolerance and resistance without previous exposure to the drug.
- organism: C. elegans
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: drug response / drug discovery
- research focus: chromatin & epigenetic regulation
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Candida albicans genetic background influences mean and heterogeneity of drug responses and genome stability during evolution to fluconazole
A. C. Gerstein, J. Berman·bioRxiv·Feb 27, 2020
- Antifungal tolerance and resistance emerge at distinct drug concentrations and rely upon different aneuploid chromosomes
F. Yang, E. F. Scopel, … J. Berman·bioRxiv·Nov 30, 2022
- The influence of drug dosing regimen on extinction and adaptation during experimental evolution in Candida albicans
Parul Sethi, Erica Pouteau, … Aleeza C. Gerstein·bioRxiv·Oct 30, 2026
- Thirty years of fluconazole therapy selects an azole-resistant Candida albicans isolate with a pre-adapted physiological, metabolic and structural state
Claudia Marcela Parra‐Giraldo, Julio Jesús Estrada‐Valbuena, … Lucía Monteoliva·bioRxiv·Sep 21, 2026
- Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole
R. J. Kukurudz, M. Chapel, … A. Gerstein·bioRxiv·Jan 6, 2022
- Candida albicans exhibits distinct cytoprotective responses to anti-fungal drugs that facilitate the evolution of drug resistance
Van Bettauer, Samira Massahi, … Michael T. Hallett·bioRxiv·Jan 21, 2020